- Home
- / ATAI Life Sciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ATAI Life Sciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.1
2024-10-29
Market Capitalization
$191.3 M
2024-10-29
Revenue
$308 K
FY, 2024
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|
| Revenue | 20.4M | 233.0K | 314.0K | 308.0K |
| General and administrative expense | 92.7M | 70.4M | 63.6M | 47.5M |
| Operating expense total | 140.7M | 144.7M | 65.6M | 47.9M |
| EBIT | (135.8M) | (144.8M) | (125.5M) | (102.7M) |
| EBIT margin, % | -666.5% | -62140.3% | -39958.9% | -33341.2% |
| Investment income | (58.6M) | (16.0M) | (3.6M) | (2.0M) |
| Interest income | 205.0K | 548.0K | 1.8M | 778.0K |
| Interest expense | 508.0K | 2.7M | 2.2M | |
| Pre tax profit | (136.6M) | (135.2M) | (39.3M) | (148.4M) |
| Income tax expense | (4.0M) | 6.2M | 1.0M | (356.0K) |
| Net Income | (174.2M) | (157.4M) | (43.9M) | (150.0M) |
| EPS | (1.0) | (0.2) | (0.9) |